Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events.

The oncologist

Volumn 14 Suppl 1, Issue , 2009, Pages 34-42

  Fandrey, Joachim ^a   Dicato, Mario ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN RECEPTOR;

ANEMIA; CELL GROWTH; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION; VENOUS THROMBOEMBOLISM;

ANEMIA; CELL GROWTH PROCESSES; HEMATINICS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; VENOUS THROMBOEMBOLISM;

EID: 73349108446     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-S1-34     Document Type: Review

References (44)